Table 2.

Impact of Additive solution treatment on the microRNA profile of platelet-derived MPs.

Top 20	Fold change	Upregulated	Fold change	Downregulated	Fold change
hsa-miR-146a-5p	0.7	hsa-let-7f-5p	2.4	hsa-miR-151a-3p	0.4
hsa-miR-151a-3p	0.4	hsa-miR-1-3p	2.3	hsa-miR-320a	0.3
hsa-miR-126-3p	1.3	hsa-miR-101-3p	2.1	hsa-miR-221-3p	0.4
hsa-miR-320a	0.3	hsa-miR-107	2.3	hsa-miR-186-5p	0.3
hsa-miR-221-3p	0.4	hsa-miR-142-3p	2.2	hsa-miR-423-5p	0.5
hsa-miR-21-5p	1.5	hsa-miR-143-3p	2.1	hsa-miR-1307-3p	0.4
hsa-miR-30d-5p	0.7	hsa-miR-144-3p	2.7	hsa-miR-320c	0.3
hsa-miR-148a-3p	1.5	hsa-miR-145-5p	3.3	hsa-miR-486-5p	0.5
hsa-let-7i-5p	1.1	hsa-miR-150-5p	2.5	hsa-miR-4433b-3p	0.4
hsa-miR-26a-5p	2.8	hsa-miR-182-5p	2.0	hsa-miR-320b	0.3
hsa-miR-423-3p	0.6	hsa-miR-199b-5p	2.3	hsa-miR-361-3p	0.5
hsa-miR-191-5p	1.1	hsa-miR-23a-3p	2.2	hsa-miR-185-3p	0.2
hsa-miR-22-3p	0.8	hsa-miR-23b-3p	3.7	hsa-miR-326	0.3
hsa-miR-186-5p	0.3	hsa-miR-26a-5p	2.8	hsa-miR-425-3p	0.4
hsa-miR-140-3p	0.7	hsa-miR-26b-5p	2.8	hsa-miR-532-5p	0.4
hsa-miR-423-5p	0.5	hsa-miR-32-5p	2.2	hsa-let-7d-3p	0.5
hsa-miR-185-5p	1.3	hsa-miR-335-3p	2.0	hsa-miR-629-5p	0.5
hsa-let-7g-5p	1.8	hsa-miR-340-3p	2.1	hsa-miR-576-3p	0.4
hsa-miR-451a	1.8	hsa-miR-3613-5p	2.8	hsa-miR-345-5p	0.4
hsa-miR-1307-3p	0.4	hsa-miR-369-3p	3.1	hsa-miR-6852-5p	0.3
		hsa-miR-379-5p	2.4	hsa-miR-1260b	0.4
		hsa-miR-410-3p	2.2	hsa-miR-769-5p	0.3
		hsa-miR-411-5p	3.0	hsa-miR-320c	0.3
		hsa-miR-487b-3p	2.4	hsa-miR-99b-3p	0.4
		hsa-miR-494-3p	2.0	hsa-miR-139-3p	0.1
				hsa-miR-2355-3p	0.3
				hsa-miR-6842-3p	0.4
				hsa-miR-760	0.3
				hsa-miR-501-3p	0.3
				hsa-miR-1908-5p	0.2
				hsa-miR-215-5p	0.4
				hsa-miR-2110	0.3
				hsa-miR-338-5p	0.4
				hsa-miR-574-3p	0.5
				hsa-miR-92b-3p	0.5
				hsa-miR-1250-5p	0.2
				hsa-miR-320d	0.2
				hsa-miR-320d	0.2
				hsa-miR-29c-5p	0.3

The 20 most abundant microRNAs are displayed, along with the microRNAs that were the most impacted (downregulated or upregulated) by Additive solution treatment.

Data are expressed as fold change vs. MPs derived from control platelets.